JP2002512029A5 - - Google Patents

Download PDF

Info

Publication number
JP2002512029A5
JP2002512029A5 JP2000544795A JP2000544795A JP2002512029A5 JP 2002512029 A5 JP2002512029 A5 JP 2002512029A5 JP 2000544795 A JP2000544795 A JP 2000544795A JP 2000544795 A JP2000544795 A JP 2000544795A JP 2002512029 A5 JP2002512029 A5 JP 2002512029A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
peptide
poly
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000544795A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002512029A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1999/002695 external-priority patent/WO1999054463A2/en
Publication of JP2002512029A publication Critical patent/JP2002512029A/ja
Publication of JP2002512029A5 publication Critical patent/JP2002512029A5/ja
Withdrawn legal-status Critical Current

Links

JP2000544795A 1998-04-21 1999-04-21 ヒトk+イオンチャンネルおよびその治療的適用 Withdrawn JP2002512029A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98107268.9 1998-04-21
EP98107268 1998-04-21
PCT/EP1999/002695 WO1999054463A2 (en) 1998-04-21 1999-04-21 Human k+ ion channel and therapeutic applications thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009160236A Division JP2009235091A (ja) 1998-04-21 2009-07-06 ヒトk+イオンチャンネルおよびその治療的適用

Publications (2)

Publication Number Publication Date
JP2002512029A JP2002512029A (ja) 2002-04-23
JP2002512029A5 true JP2002512029A5 (cg-RX-API-DMAC7.html) 2006-06-15

Family

ID=8231794

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000544795A Withdrawn JP2002512029A (ja) 1998-04-21 1999-04-21 ヒトk+イオンチャンネルおよびその治療的適用
JP2009160236A Pending JP2009235091A (ja) 1998-04-21 2009-07-06 ヒトk+イオンチャンネルおよびその治療的適用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009160236A Pending JP2009235091A (ja) 1998-04-21 2009-07-06 ヒトk+イオンチャンネルおよびその治療的適用

Country Status (10)

Country Link
US (7) US6638736B1 (cg-RX-API-DMAC7.html)
EP (1) EP1073738B1 (cg-RX-API-DMAC7.html)
JP (2) JP2002512029A (cg-RX-API-DMAC7.html)
AT (1) ATE278017T1 (cg-RX-API-DMAC7.html)
CA (1) CA2323571A1 (cg-RX-API-DMAC7.html)
DE (1) DE69920681T2 (cg-RX-API-DMAC7.html)
DK (1) DK1073738T3 (cg-RX-API-DMAC7.html)
ES (1) ES2230852T3 (cg-RX-API-DMAC7.html)
PT (1) PT1073738E (cg-RX-API-DMAC7.html)
WO (1) WO1999054463A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1073738E (pt) * 1998-04-21 2005-01-31 Max Planck Ges Forderung Der W Canal do iao k+ de seres humanos e as suas aplicacoes terapeuticas
DE10025620A1 (de) * 2000-05-24 2001-12-06 Forschungsgesellschaft Genion Verfahren zur Herstellung von Chimären zwischen bakteriellen und eukaryotischen Kaliumkanälen auf festen Trägern und deren Verwendung zur Identifizierung von Kaliumkanalagonisten und -antagonisten
DE10224534A1 (de) * 2002-05-31 2003-12-11 Juergen Dolderer Verfahren zum Diagnostizieren des colorektaien Karzinoms in einer Gewebeprobe und Mittel zur Behandlung
WO2006037611A2 (en) * 2004-10-01 2006-04-13 Centro De Investigación Y De Estudios Avanzados Del Ipn Methods for the early diagnosis of viral infections, inflammatory diseases, a predisposition for proliferative disorders or hyperplasia by analysing eag or erg expression levels
WO2006037604A1 (en) * 2004-10-01 2006-04-13 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Novel antibodies directed to the mammalian eag1 ion channel protein
AU2013201604B2 (en) * 2007-04-13 2014-08-14 Southern Research Institute Anti-angiogenic agents and methods of use
ES2334084B1 (es) * 2007-12-21 2011-01-24 Inst Cientifico Tecnol Navarra Marcadores geneticos para el pronostico de la esclerosis multiple.
US8892184B2 (en) 2010-10-18 2014-11-18 Siemens Medical Solutions Usa, Inc. Systems and methods for reducing interference in a dual modality imaging system
TWI570415B (zh) * 2015-10-02 2017-02-11 A spring probe having an outer sleeve and a probe device having the spring probe
EP3195727A1 (en) 2016-01-22 2017-07-26 Forschungsinstitut Fur Biologischen Landbau (FiBL) Duddingtonia flagrans strain and feed additive formulation for biological pest control

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394448A (en) * 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
GB9303210D0 (en) 1993-02-17 1993-03-31 Univ Manitoba Cancer treatment
DE69120430D1 (de) 1990-12-18 1996-07-25 Wellcome Found Mittel zur verstaerkung der wirkung von antitumoralen mittel und zur widerstandsbekaempfung von vielfachdrogen
CA2258513A1 (en) * 1996-07-02 1998-01-08 Beat Schmid Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds
US6610827B1 (en) * 1997-10-29 2003-08-26 Elan Pharmaceuticals, Inc. Potassium channel subunit polypeptide and polynucleotide compositions and uses therefor
PT1073738E (pt) * 1998-04-21 2005-01-31 Max Planck Ges Forderung Der W Canal do iao k+ de seres humanos e as suas aplicacoes terapeuticas

Similar Documents

Publication Publication Date Title
ES2661310T3 (es) Proteínas mirac
JP2025020207A (ja) 血液脳関門の標的化に有用な組成物および方法
WO2002008261A2 (en) Bstp-trans protein and related reagents and methods of use thereof
JP2007506417A5 (cg-RX-API-DMAC7.html)
US6417338B1 (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
JP2007524622A (ja) 抗癌治療に対する腫瘍細胞の感受性を回復させてアポトーシスを誘導するための組成物及び方法
TW416960B (en) Reshaped human antibody to human interleukin-8
WO2002008260A9 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
WO2012015836A1 (en) Highly potent peptides to control cancer and neurodegenerative diseases
KR960015442B1 (ko) 맥관인자
WO2023179789A1 (zh) 干扰趋化素样因子超家族成员6(cmtm6)表达的基因治疗载体的制备和抗肿瘤应用
JP2003534786A (ja) 化学療法および放射線感作物質を用いた腫瘍性疾患を処置するための組成物および方法
US20040241756A1 (en) Methods and means of histone methylation
CN108329387B (zh) 癌症相关的肿瘤特异转录本lin28b-tst及其用途
CN114796525A (zh) 细胞周期调控蛋白抑制剂在肿瘤治疗中的应用
CN106701902B (zh) Foxr2基因和表达产物在肝癌诊断与治疗中的应用
US10314889B2 (en) Suppression of allergic lung inflammation and hyperreactivity
JP2001516568A (ja) 医薬および診断剤の調製のためのプレセニリン1阻害を確実にする化合物
CN111139299B (zh) Josd2蛋白在制备治疗恶性肿瘤药物中的应用
CN113398270B (zh) 一种治疗骨巨细胞瘤的方法
CN116715761B (zh) 一种治疗性单克隆抗体及应用
CN120714014B (zh) 基因敲除msh2的肿瘤细胞疫苗及其制备方法和用途
US20030153730A1 (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
CN100480264C (zh) 一种广谱抑制癌细胞生长的蚯蚓蛋白及其编码序列
WO2003084998A1 (fr) Anticorps monoclonal neutralisant la megsine